Fatal HHV6 infection in an immunocompromised patient presenting with skin involvement

Journal of Cutaneous Pathology

Volumn 37, Issue 2, 2010, Pages 277-281

  Galan, Anjela ^a   McNiff, Jennifer M ^a   Choi, Jennifer Nam ^a   Lazova, Rossitza ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE PROGRESSION; FATAL OUTCOME; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INCLUSION BODIES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS; SKIN;

EID: 74049157105     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01291.x     Document Type: Article

References (20)

1. Braun DK, Dominguez G, Pellett PE. Human herpesvirus-6. Clin Microbiol Rev 1997 10 : 521.
2. Sallahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986 234 : 596.
3. Josephs SF, Salahuddin SZ, Ablashi DV, et al. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 1986 234 : 601.
4. Ablashi DV, Salahuddin SZ, Josephs SF, et al. HBLV (or HHV6) in human cell lines. Nature 1987 329 : 207.
5. Gompels UA, Nicholas J, Lawrence G, et al. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995 209 : 29.
6. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 1996 70 : 5975.
7. Nicholas J, Martin ME. Nucleotide sequence analysis of a 38.5 kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J Virol 1994 68 : 597.
8. Ablashi DV, Balachandran N, Joseph SF, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991 184 : 545.
9. Lusso P. Human herpesvirus 6 (HHV-6). Antiviral Res 1996 31 : 1.
10. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 1999 5 (3 353.
11. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996 124 (12 1065.
12. Weedon D. Skin pathology, 2nd ed. London : Churchill Livingstone, 2002 692.
13. Katzenstein A. A. Katzenstein and Askin's surgical pathology of non-neoplastic lung disease, 4th ed. Philadelphia : Saunders Esevier 2006 261.
14. Galan A, Rauch CA, Otis CN. Fatal BK polyoma viral pneumonia associated with immunosuppression. Hum Pathol 2005 36 (9 1031.
15. Facchetti F, Vermi W, Mason D. The plasmacytoid monocyte/ interferon producing cells. Virchows Arch 2003 443 : 703.
16. Giraud S, Dhedin N, Gary-Gouy, Lebon P, Vernant JP, Dalloul A. Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus. J interferon Cytokine Res 2005 25 : 135.
17. Carlson JA, Perlmutter A, Tobin E, Richardson D, Rohwedder A. Adverse antibiotic-induced eruptions associated with Epstein-Barr virus infection and showing Kikuchi-Fugimoto disease-like histology. Am J Dermatopathol 2006 28 : 48.
18. Arpinati M, Chirumbolo G, Saunthararajah Y, et al. Higher number of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. Biol Blood Marrow Transplant 2007 13 : 228.
19. Ratnamohan VM, Chapman J, Howse H, et al. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. Transplantation 1998 66 : 877.
20. Kvale E, Dalgaard J, Lund-Johansen F, et al. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006 107 (5 2022.